Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 52

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 52
---
(UNAUDITED)

NOTE
1 — ORGANIZATION AND BUSINESS 

All
references in this report to “Milestone Scientific,” “us,” “our,” “we,” the “Company”
or “Milestone” refer to Milestone Scientific Inc., and its consolidated subsidiaries, Wand Dental, Inc., and Milestone Innovations
Inc. and Milestone Education LLC (all described below), unless the context otherwise indicates. Milestone Scientific is the owner of
the following registered U.S. trademarks: CompuDent®; CompuMed®; CompuFlo®; DPS Dynamic Pressure
Sensing technology®; Milestone Scientific ®; the Milestone logo ®; SafetyWand®;
STA Single Tooth Anesthesia System®; and The Wand ®. 

Milestone
Scientific was incorporated in the State of Delaware in August 1989. Milestone Scientific has developed a proprietary, computer-controlled
anesthetic delivery device, using The Wand®, a single use disposable handpiece. The device is marketed in dentistry under
the trademarks CompuDent® and STA Single Tooth Anesthesia System®, and in medicine under the trademark CompuMed®.
CompuDent® is suitable for all dental procedures that require a local anesthetic. CompuMed® is suitable for many
medical procedures regularly performed in plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, orthopedics,
and many other disciplines. The dental devices are sold in the United States, Canada, and 49 other countries. Specific medical
devices have obtained CE mark approval and can be marketed and sold in most European countries. In June 2017, Milestone
Scientific received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) on the CompuFlo®
Epidural Computer Controlled Anesthesia System (“Epidural”). 

NOTE
2--GOING CONCERN AND LIQUIDITY

Our
financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of
the Company on a going concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished in the
ordinary course of business at amounts disclosed in the unaudited condensed financial statements.

The Company has incurred aggregate losses of
approximately $132.7
million since its inception. Operating losses were approximately $1.1
million and $4.6
million for the three and